New York-based clinical-stage cancer and rare diseases drug developer Protara Therapeutics today announced that the US Food ...

London-based drugmaker GSK has announced the UK approval of Nucala (mepolizumab) as an add-on maintenance biologic treatment ...

Wegovy (semaglutide) pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 ...

Shares of US immunology focused biotech Zenas BioPharma tumbled more than 50% to $17.08 pre-market today despite announcing ...

China-based Insilico Medicine, an AI-driven drug discovery firm, announced a multi-year research and development (R&D) ...

Suzhou-based Otovia Therapeutics has raised close to 100 million yuan ($14 million) in a new financing round, with support ...

Paul Burden (pictured, above) has been appointed associate vice president and country head of Accord UK, effective ...

Chinese RNA drug developer Ribo has launched a Hong Kong IPO, positioning its lead siRNA candidate for thrombotic diseases as ...

San Diego, USA-based ARS Pharmaceuticals has announced that China’s National Medical Products Administration (NMPA) has ...

The sales of the anti-cancer agent Jevtana IV Infusion 60 mg (cabazitaxel) will be transferred from French pharma major ...

Taiwanese drugmaker ScinoPharm (TWSE: 1789) has secured approval from the US Food and Drug Administration for its glatiramer ...

Swiss pharma Idorsia saw its shares rise 8% to 4.60 francs in early trading today after it announced that Health Canada has ...